{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:28:12Z","timestamp":1792675692375,"version":"4.5.0"},"reference-count":15,"publisher":"Scientific Foundation Spiroski (publications)","issue":"1","license":[{"start":{"date-parts":[[2019,1,13]],"date-time":"2019-01-13T00:00:00Z","timestamp":1547337600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Open Access Maced J Med Sci"],"abstract":"<jats:p>AIM: This study aims to evaluate the methods of treatment of the thoracic part of oesophagal cancer and to predict the results of treatment depending on the factors of the prognosis.\r\nMATERIALS AND METHODS: The results of treatment of 366 patients with cancer of the thoracic part of the oesophagus for 10 years (2007-2016) by the department of thoracic oncology of the Karaganda oncological dispensary were studied.\r\nRESULTS: The overall five-year survival rate, regardless of the method of treatment, was only 8.72% (28 of 321), and in the 6-10 year period 8.41% (27 of 321) lived, p &lt; 0.05. Analysis of the overall survival of patients with\u00a0cancer of the thoracic part of oesophagus showed that the method of treatment does not have a significant effect on life expectancy. A multivariate analysis of 19 grades that affect the prognosis of the disease was carried out.\r\nCONCLUSION: Radical type of treatment of the middle and lower thoracic oesophagus is surgical, in which the median of cumulative survival is 19 months. Traditional radiotherapy should be used in a limited way, as it is palliative, with a median survival of no more than 9 months. The leading factor in the prognosis for thoracic part of oesophagal cancer is the presence of regional metastases, on which the choice of method of treatment depends.<\/jats:p>","DOI":"10.3889\/oamjms.2019.023","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T18:58:47Z","timestamp":1547665127000},"page":"82-87","source":"Crossref","is-referenced-by-count":5,"title":["Analysis of Treatment Results of the Thoracic Part of Oesophageal Cancer"],"prefix":"10.3889","volume":"7","author":[{"given":"Bekzhan Alipbayevich","family":"Orazbayev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kani","family":"Musulmanbekov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akat","family":"Bukenov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"52292","published-online":{"date-parts":[[2019,1,13]]},"reference":[{"key":"61545","doi-asserted-by":"crossref","unstructured":"Axel EM. Statistics of malignant neoplasms of the gastrointestinal tract. Siberian Oncological Journal. 2017; 16(3):5-11. https:\/\/doi.org\/10.21294\/1814-4861-2017-3-5-11","DOI":"10.21294\/1814-4861-2017-3-5-11"},{"key":"61546","unstructured":"Litvinov RP, Chernykh MV, Nechushkin MI. Brachytherapy of esophageal cancer with localization as a component of radical treatment: advantages and risks. Malignant tumors. 2016; 4:109-114."},{"key":"61547","unstructured":"Roman LD, Shostka KG, Arutyunyan KV, and others. Possibilities of surgical treatment of complicated forms of locally advanced thoracic esophagus cancer. Preventive and Clinical Medicine. 2016; 3(60):67-71."},{"key":"61548","unstructured":"Kanaev SV, Shcherbakov AM, Tiuriaeva EI, Avanesian AA. Conservative treatment of locally advanced and inoperable esophageal cancer: possible methods and future directions. Voprosy onkologii. 2012; 58(2):199-202. PMid:22774524"},{"key":"61549","unstructured":"Mamontov AS. Combined treatment of esophageal cancer. Practical Oncology. 2003; 4(2):76-82."},{"key":"61550","unstructured":"Kube R, Reimer A, Kluge E et al. Surgical treatment of esophageal malignant neoplasms. Surgery; 2009; 9:50-54."},{"key":"61551","unstructured":"Karpov DV, Kaminsky YuD, Grigoriev AV, Karpova LI. Prognostic factors and their influence on the results of treatment of esophageal cancer. Science of the Young. 2013; 4(2):39-51."},{"key":"61552","unstructured":"Chissov VI, Daryalova SL. Oncology-M: GEOTAR-Media. 2007; 560."},{"key":"61553","doi-asserted-by":"crossref","unstructured":"Orringer MB, Marshall B, Chang AC, Lee J, Pickens A, Lau CL. Two thousand transhiatal esophagectomies: changing trends, lessons learned. Annals of surgery. 2007; 246(3):363. https:\/\/doi.org\/10.1097\/SLA.0b013e31814697f2 PMid:17717440 PMCid:PMC1959358","DOI":"10.1097\/SLA.0b013e31814697f2"},{"key":"61554","doi-asserted-by":"crossref","unstructured":"Anil KR, Hashem BE. Esophageal Carcinoma. N Engl J Med. 2014; 371:2499-2509. https:\/\/doi.org\/10.1056\/NEJMra1314530 PMid:25539106","DOI":"10.1056\/NEJMra1314530"},{"key":"61555","doi-asserted-by":"crossref","unstructured":"Stilidi I, Davydov M, Bokhyan V, Suleymanov E. Subtotal esophagectomy with extended 2-field lymph node dissection for thoracic esophageal cancer. European journal of cardio-thoracic surgery. 2003; 23(3):415-20. https:\/\/doi.org\/10.1016\/s1010-7940(02)00801-1","DOI":"10.1016\/s1010-7940(02)00801-1"},{"key":"61556","doi-asserted-by":"crossref","unstructured":"Napier KJ, Scheerer M, Misra S. Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities. World journal of gastrointestinal oncology. 2014; 6(5):112. https:\/\/doi.org\/10.4251\/wjgo.v6.i5.112 PMid:24834141 PMCid:PMC4021327","DOI":"10.4251\/wjgo.v6.i5.112"},{"key":"61557","doi-asserted-by":"crossref","unstructured":"Isono K, Ochiai T, Okuyama K, Onoda S. The treatment of lymph node metastasis from esophageal cancer by extensive lymphadenectomy. The Japanese journal of surgery. 1990; 20(2):151-7. https:\/\/doi.org\/10.1007\/BF02470762 PMid:2342235","DOI":"10.1007\/BF02470762"},{"key":"61558","doi-asserted-by":"crossref","unstructured":"Altorki N, Kent M, Ferrara C, Port J. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Annals of surgery. 2002; 236(2):177. https:\/\/doi.org\/10.1097\/00000658-200208000-00005 PMid:12170022 PMCid:PMC1422563","DOI":"10.1097\/00000658-200208000-00005"},{"key":"61559","unstructured":"Dengina NV. Modern therapeutic opportunities in cancer of the esophagus. Practical Oncology. 2012; 4:276-288."}],"container-title":["Open Access Macedonian Journal of Medical Sciences"],"original-title":[],"link":[{"URL":"https:\/\/oamjms.eu\/index.php\/mjms\/article\/download\/oamjms.2019.023\/2753","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/oamjms.eu\/index.php\/mjms\/article\/download\/oamjms.2019.023\/2782","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T08:47:53Z","timestamp":1692521273000},"score":1,"resource":{"primary":{"URL":"https:\/\/oamjms.eu\/index.php\/mjms\/article\/view\/oamjms.2019.023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,13]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,15]]}},"URL":"https:\/\/doi.org\/10.3889\/oamjms.2019.023","relation":{},"ISSN":["1857-9655"],"issn-type":[{"value":"1857-9655","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,13]]}}}